< Back to latest news & events

Event

IAM Pharma & Biotech IP Summit 2020 – London

January 2020

Event date: 28th January 2020

HGF is a gold sponsor at IAM Pharma & Biotech IP Summit on 28th January 2020 with Partner Douglas Drysdale and Patent Director Dr Emma Longland attending the event.

The life sciences are in a period of dramatic change and innovation with developments in new technologies challenging traditional IP strategies and business models. IAM’s Pharma and Biotech IP will bring together leading in-house practitioners and expert counsel to discuss next-generation strategies for protecting and exploiting cutting-edge innovation.

HGF Partner Douglas Drysdale will be attending and joining a panel to discuss Protecting the next generation of therapies:

A wave of cutting-edge technologies – from personalised medicines to gene and cell therapies – have become the focus of innovation in the life sciences, raising new challenges for IP professionals. An expert panel will shed light on:

  • The patentability questions raised by new technologies
  • How to gain the strongest possible protection for these technologies
  • Relevant international differences

HGF Patent Director Dr Emma Longland will also be attending.

Register here

Attendees

Douglas
Drysdale

Latest updates

Celebrating Success – Director Promotions

We are proud to announce that 7 of our team have been promoted to director effective from 1 December 2024! These promotions recognise the outstanding contributions demonstrated by these individuals, who …

Read article

The Board of Appeal refers questions to the Enlarged Board of Appeal regarding case T1286/23

In T1286/23 (https://www.epo.org/en/boards-of-appeal/decisions/t231286ex1), the Board of Appeal has referred the following questions to the Enlarged Board of Appeal: After the withdrawal of all appeals, may the proceedings be continued with …

Read article

UPC first FRAND judgment results in injunction against OPPO

Panasonic Holdings Corporation v Guangdong OPPO Mobile Telecommunications Corp. Ltd & anor UPC_CFI_210/2023 – Mannheim Local Division (Tochtermann, Böttcher, Brinkman & Loibner) – 22 November 2024. The UPC issued its …

Read article

The IP Lawyer’s Cheat Sheet: Lucy Johnson on Innovation, Legislation, and Strategy

The world of intellectual property is on the brink of significant transformation. From navigating the use of AI technology to staying ahead of increasingly sophisticated bad actors, IP professionals must …

Read article

Edwards v Meril confirms UPC’s jurisdiction over acts of infringement before the court came into force

In Edwards v Meril (UPC_CGI_15/2023), the UPC’s Munich local division refused to stay infringement proceedings pending an appeal on the central division’s finding of validity of the patent in amended …

Read article

Njoy v Juul finds the patent's underlying problem despite no mention of the problem in the specification

In Njoy v Juul (UPC CFI 315 /2023), the Paris Division of the Central Division provides further insight into the UPC’s approach to inventive step. Of critical importance in assessing …

Read article
See all updates